Conversations on Health Care
FDA Advisor Dr. Offit’s Latest Findings on COVID Vaccine & Young Children
FDA vaccine advisor Dr. Paul Offit’s recent article in JAMA Pediatrics looks at the millions of 5- to 11-year-old children who received the COVID vaccine.
This content is provided by Community Health Center, Inc.
FDA vaccine advisor Dr. Paul Offit’s recent article in JAMA Pediatrics looks at the millions of 5- to 11-year-old children who received the COVID vaccine.
His in-depth research review found that the mRNA vaccine was effective at preventing COVID, symptomatic infection, hospitalization, and multisystem inflammatory syndrome in children. The vaccine was also safe; myocarditis occurred in very rare cases.
Dr. Offit joins hosts Mark Masselli and Margaret Flinter to discuss his findings and why he supports the end of the public health emergency.
Copyright © 2024 Federal News Network. All rights reserved. This website is not intended for users located within the European Economic Area.
